Lexeo Therapeutics Balance Sheet (2022-2026) | LXEO

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter) 94.15M77.33M35.45M121.47M195.10M175.00M157.00M35.01M28.91M35.48M41.00M63.00M71.77M
Short-term Investments (Quarter) 86.50M70.92M97.41M81.77M118.77M121.28M
Cash & Current Investments (Quarter) 94.15M77.33M35.45M121.47M195.10M175.00M157.00M121.52M99.83M132.89M122.76M181.77M193.04M
Prepaid Assets (Quarter) 0.37M1.41M2.83M3.03M2.17M2.44M4.60M5.44M7.17M5.03M6.62M7.82M
Current Assets (Quarter) 80.05M38.87M124.29M198.09M177.15M159.46M126.12M105.27M140.06M127.79M188.39M200.86M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 1.00M0.98M1.06M1.04M1.21M1.18M1.03M1.04M1.11M1.23M1.14M1.10M
Long-Term Investments (Quarter) 7.04M3.39M3.39M3.39M3.39M
Other Non-Current Assets (Quarter) 3.25M3.25M3.25M3.25M3.25M3.25M3.25M3.25M3.25M3.25M3.25M3.25M3.25M
Non-Current Assets (Quarter) 17.03M15.85M15.51M15.12M14.86M14.41M20.82M20.42M36.01M16.05M80.30M49.49M
Assets (Quarter) 97.08M54.72M139.81M213.21M192.01M173.87M146.94M125.69M176.07M143.84M268.69M250.36M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 2.68M2.65M3.79M4.30M5.76M8.44M6.42M11.98M20.02M4.66M4.86M3.33M
Notes Payables (Quarter) 4.15M
Payables (Quarter) 2.68M6.80M3.79M4.30M5.76M8.44M6.42M11.98M20.02M4.66M4.86M3.33M
Accumulated Expenses (Quarter) 6.42M1.82M10.84M13.77M1.90M15.70M4.11M16.20M2.21M2.98M9.28M8.16M
Other Accumulated Expenses (Quarter) 0.24M0.18M0.55M0.18M0.18M0.55M0.55M0.67M0.19M0.21M0.07M0.10M
Current Leases (Quarter) 2.29M2.08M2.09M2.09M2.10M2.11M2.10M0.52M2.14M2.15M0.52M2.17M
Current Taxes (Quarter) 0.51M0.02M0.16M0.15M0.04M
Total Current Liabilities (Quarter) 14.35M23.04M17.24M21.63M18.88M26.82M22.85M30.82M31.59M17.27M16.81M14.19M
Non-Current Liabilities
Capital Leases (Quarter) 1.65M1.35M1.25M1.15M1.04M0.93M0.82M0.70M0.58M0.45M0.33M0.20M
Preferred Stock Liabilities (Quarter) 185.03M185.03M185.03M185.03M99.77M
Operating Leases (Quarter) 9.00M8.11M7.79M7.47M7.14M6.79M6.44M6.05M5.68M5.29M4.88M4.47M
Other Non-Current Liabilities (Quarter) 4.10M
Total Non-Current Liabilities (Quarter) 28.40M
Total Liabilities (Quarter) 98.98M25.00M131.18M143.62M32.50M26.27M30.25M27.06M34.54M30.10M37.58M37.85M23.01M22.02M18.86M
Shareholder's Equity
Common Equity (Quarter) -98.98M-112.95M-131.18M-143.62M-162.81M113.53M182.95M164.95M139.33M116.84M88.11M138.22M120.83M246.67M231.50M
Shareholder's Equity (Quarter) -98.98M-112.95M-131.18M-143.62M-162.81M113.53M182.95M164.95M139.33M116.84M88.11M138.22M120.83M246.67M231.50M
Liabilities and Shareholders Equity (Quarter) 97.08M54.72M139.81M213.21M192.01M173.87M146.94M125.69M176.07M143.84M268.69M250.36M
Treasury Shares (Quarter) 0.22M0.27M0.00M0.27M0.74M0.00M0.70M0.38M
Retained Earnings (Quarter) -115.45M-167.65M-181.84M-224.80M-224.76M-254.25M-280.17M-312.83M-338.90M0.09M0.19M-0.14M
Preferred Shares (Quarter) 185.56M